PLAY PODCASTS
Individualizing HIV ART: Rapid Start
Episode 269

Individualizing HIV ART: Rapid Start

Listen to Daniel R. Kuritzkes, MD, discuss considerations for rapid start of antiretroviral therapy in patients newly diagnosed with HIV, including management of patients with a history of receiving PrEP.

Decera Clinical Education Infectious Disease Podcast · Daniel R. Kuritzkes MD

April 13, 20234m 28s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Daniel R. Kuritzkes, MD, discusses considerations for rapid initiation of antiretroviral therapy in patients who are newly diagnosed with HIV, including:

  • Recommended regimens
  • Management of patients previously receiving PrEP
  • Timing of laboratory testing

Presenter:

Daniel R. Kuritzkes, MD
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Chief, Division of Infectious Diseases
Brigham and Women’s Hospital
Boston, Massachusetts

To download the slides: 
https://bit.ly/3odUA9C

To view the full online program: 
https://bit.ly/3ZjSFhg


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

boosted piias-usacabotegravirdhhspeople with hivritonavirdolutegravir preprapidcobicistatadherence counselingboosted protease inhibitorrapid artpreexposure prophylaxisbictegravirdarunavirgenotypic testingrapid startinstigenotypeadherencehivpwh